Microban Helps Medical Manufacturers Address HAIs

Article

Microban International, a global leader in built-in antimicrobial product protection, announced today a new initiative designed to help medical device manufacturers get to market quicker with antimicrobial solutions for 510(k) registered medical devices used in hospitals and other healthcare facilities.

Helthcare-acquired infections (HAIs) are responsible for approximately 100,000 deaths per year and incur in excess of $20 billion in healthcare costs. "Our expertise utilizing a breadth of antimicrobial technologies enables us to help manufacturers of medical devices develop safer and more effective antimicrobial solutions for their products and provides an important resource to help address the growing concern over hospital acquired infections," said David Meyers, president and CEO of Microban International.

Microban has an extensive portfolio of organic, inorganic and organometallic antimicrobial technologies which enable it to choose the optimal technology for the device. It works closely with customers to engineer antimicrobial solutions that are designed to meet the specific needs of each unique device application, evaluating important criteria such as: antimicrobial performance utilizing industry standard protocols and testing for specific microorganisms and relevant kill times; durability requirements and exposure time periods; product usage environment; manufacturing parameters; and necessary regulatory approvals.

With more than 20 years of experience engineering antimicrobial solutions across a breadth of product applications and materials including expertise with thermoplastics, cross-linked thermosets, coatings and textiles Microban says it can help medical device manufacturers to more effectively and accurately screen and optimize potential antimicrobial technologies.  In addition, its onsite state-of-the-art microbiology laboratory utilizes a high throughput quantitative testing system that enables Microban to quickly and reliably deliver accurate data and proof of concept studies.

Microban offers full service support and project management including engineering services, on-site microbiology, analytical efficacy testing and regulatory guidance.  For more information, medical manufacturers should visit http://www.microban.com/microban-medical.

 

Recent Videos
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Related Content